STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo - Wikidata - wikimedia - TriplyDB

STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo

STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo

http://www.wikidata.org/entity/Q35015488

about

Improving the clinical impact of biomaterials in cancer immunotherapy.Progress toward in vivo use of siRNAs-II Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.Current position of TNF-α in melanomagenesis.Delivery strategies and potential targets for siRNA in major cancer types Off-target effects of plasmid-transcribed shRNAs on NFκB signaling pathway and cell survival of human melanoma cells.Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor.

P2860

Q26766267-7680BF40-1892-4258-9E92-20F2E9A2C2EB Q28255877-1DE4A510-179F-4D47-B9B7-C82AB6FDD978 Q35138155-AC526992-DF5C-44CC-9CA3-04BF60970FBA Q38567932-47103875-3FA8-40AD-BF99-6070728800CA Q38853191-A5A8C813-B706-4192-8979-DDFCA0A41BB8 Q39068964-F4554C28-7635-4355-8EFC-C2FEE8E70522 Q39134511-D813AE02-C5C7-4495-9DE3-DC4C86CAE6F5 Q39186157-A6C409A2-3322-4BBB-B988-686931B02454

P2860

STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo

http://www.wikidata.org/entity/Q35015488

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

STAT3 Knockdown in B16 Melanom ...... Response In Vitro and In Vivo

@ast

STAT3 Knockdown in B16 Melanom ...... Response In Vitro and In Vivo

@en

type

label

STAT3 Knockdown in B16 Melanom ...... Response In Vitro and In Vivo

@ast

STAT3 Knockdown in B16 Melanom ...... Response In Vitro and In Vivo

@en

prefLabel

STAT3 Knockdown in B16 Melanom ...... Response In Vitro and In Vivo

@ast

STAT3 Knockdown in B16 Melanom ...... Response In Vitro and In Vivo

@en

P1433

Q35015488-D2094AF4-9B91-4674-8712-09565B8C9873

P1476

Q35015488-4A63EA14-EED0-4618-9EA0-92361D084C7B

P2093

Q35015488-132327B1-D29F-4B23-83C0-10ABF8B8DE92

Q35015488-1CADFBF3-79A5-4679-9017-EBB957893CB9

Q35015488-35CF6A87-4287-4D6C-B898-190EC43D266D

Q35015488-BEE81FDE-FBDE-410F-92BC-9C4C5B8CFCC5

Q35015488-D2599023-70FB-4755-83C8-AE2C3D8DCCDF

Q35015488-DB2EE336-BDB1-48B5-9B19-131765659545

Q35015488-DB3A5BC6-1650-4042-9B96-F0FC8D959732

P2860

Q35015488-02175AA6-B83C-4043-8E2D-DFD411ADA30D

Q35015488-0DC9A9B7-4E00-4C50-828C-29149BA257E9

Q35015488-0F25F750-AAA1-4D2D-BE27-5F33CF8D4A4B

Q35015488-27660A6C-A9EF-4769-A317-58A78FE66562

Q35015488-309CA82A-5F53-46E4-890F-ECDFAF2323A8

Q35015488-37EA9F90-FC14-425E-A46E-8ECB593D2B14

Q35015488-40972A6A-CC23-4A1F-AA31-E96E3CE64AC1

Q35015488-4259A41E-9139-4FEA-8F90-D33729A09E02

Q35015488-45A54D60-9EC8-4BA8-8F2F-F73DBEE74BBF

Q35015488-5683950B-5302-4D8B-A484-F00420D4C15C

P304

Q35015488-EF4D69D9-60CA-4431-BA3A-2002D1BE31E4

P31

Q35015488-A6C96F59-527D-4C3A-A720-073D13C22152

P356

Q35015488-551B1D10-8579-4523-A3C9-2836DE41AC10

P433

Q35015488-A5559D01-4054-44A0-BB0A-9D86C243C1DE

P478

Q35015488-EBB680F4-8B2D-4880-978B-F28A0E1DF6CB

P577

Q35015488-68971EA9-4612-400E-86AC-C84D79EB07E6

P5875

Q35015488-63010700-7A5A-4256-945A-F8F66CF6A63E

P698

Q35015488-3616955A-AF00-4813-B8B1-704529ABE60C

P932

Q35015488-F48E2D90-DB96-4E84-A844-229B8A6DD7C1

P356

P1433

Translational Oncology

P1476

STAT3 Knockdown in B16 Melanom ...... Response In Vitro and In Vivo

@en

P2093

Afsaneh Lavasanifar

http://www.w3.org/2001/XMLSchema#string

Aws Alshamsan

http://www.w3.org/2001/XMLSchema#string

Ayman O S El-Kadi

http://www.w3.org/2001/XMLSchema#string

Azita Haddadi

http://www.w3.org/2001/XMLSchema#string

Hasan Uludağ

http://www.w3.org/2001/XMLSchema#string

John Samuel

http://www.w3.org/2001/XMLSchema#string

Samar Hamdy

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

Regulation of interferon-gamma during innate and adaptive immune responses

Interleukin-12 and the regulation of innate resistance and adaptive immunity

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.

Cell biology of antigen processing in vitro and in vivo.

Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway

Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.

Does the immune system see tumors as foreign or self?

P304

178-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/TLO.11100

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51184946

http://www.w3.org/2001/XMLSchema#string

P698

21633673

http://www.w3.org/2001/XMLSchema#string

P932

3104698

http://www.w3.org/2001/XMLSchema#string